75 related articles for article (PubMed ID: 2458833)
1. Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma.
Christensen L; Nielsen M; Andersen J; Clemmensen I
Cancer Res; 1988 Nov; 48(21):6227-33. PubMed ID: 2458833
[TBL] [Abstract][Full Text] [Related]
2. Laminin production and fibronectin immunoreactivity in breast carcinomas.
Gorczyca W; Holm R; Nesland JM
Anticancer Res; 1993; 13(4):851-8. PubMed ID: 8394677
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
5. Cysteine proteinase inhibitor cystatin A in breast cancer.
Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin: a discrimination marker between small invasive carcinomas and benign proliferative lesions of the breast.
Christensen L
APMIS; 1990 Jul; 98(7):615-23. PubMed ID: 2397113
[TBL] [Abstract][Full Text] [Related]
7. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between laminin and fibronectin on the basement membrane and tumor progression in early gastric cancer: an immunohistochemical study].
Fujita J
Hokkaido Igaku Zasshi; 2000 Jan; 75(1):25-34. PubMed ID: 10736758
[TBL] [Abstract][Full Text] [Related]
10. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
11. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
[TBL] [Abstract][Full Text] [Related]
14. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
16. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
Moore KH; Thaler HT; Tan LK; Borgen PI; Cody HS
Cancer; 2004 Mar; 100(5):929-34. PubMed ID: 14983487
[TBL] [Abstract][Full Text] [Related]
18. The effect of tumor size and lymph node status on breast carcinoma lethality.
Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B
Cancer; 2003 Nov; 98(10):2133-43. PubMed ID: 14601082
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
[TBL] [Abstract][Full Text] [Related]
20. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.
Madjd Z; Parsons T; Watson NF; Spendlove I; Ellis I; Durrant LG
Breast Cancer Res; 2005; 7(5):R780-7. PubMed ID: 16168124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
